NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," “Aptorum” or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs in oncology and infectious diseases, and DiamiR Biosciences (“DiamiR”), a developer of proprietary innovative blood-based tests for brain health and other diseases with a CLIA licensed, CAP accredited clinical laboratory in New Haven, CT, today announced that they have entered into a definitive agreement for an all-stock merger transaction, in which DiamiR Biosciences will retain its name and become a wholly-owned subsidiary of Aptorum Group upon consummation of the merger.The combined company expects to remain listed on the Nasdaq Stock Market following the closing of the merger.
TAMPERE, Finland, July 16, 2025 /PRNewswire/ -- Treon, a leading IoT technology company, has announced a long term strategic partnership with Forbes Marshall, a...
TAMPERE, Finland, July 16, 2025 /PRNewswire/ -- Treon, a leading IoT technology company, has announced a long term strategic partnership with Forbes Marshall, a...
Smart connected solutions with energy saving regenerative drive technologyKUALA LUMPUR, Malaysia, July 16, 2025 /PRNewswire/ -- Otis (NYSE: OTIS) will provide innovative technology and connected vertical mobility...
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options
AKRON, Ohio, July 15, 2025 /PRNewswire/ -- FirstEnergy Corp. (NYSE: FE) Board Chair, President and CEO Brian X. Tierney addressed government officials, global investors...
XIAMEN, China, July 15, 2025 /PRNewswire/ -- Milesight, a leading innovator in intelligent IoT products, today announces the official launch of the CamThink brand,...
XIAMEN, China, July 15, 2025 /PRNewswire/ -- Milesight, a leading innovator in intelligent IoT products, today announces the official launch of the CamThink brand,...